EQNR(EQNR)
EQNR
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $122.45B | $108.84B | $102.19B | $92.88B | $92.20B |
| Low | $107.50B | $103.06B | $100.99B | $82.77B | $82.16B |
| High | $142.18B | $117.13B | $103.40B | $106.93B | $106.15B |
| EBITDA Avg | $56.14B | $49.90B | $46.85B | $42.58B | $42.27B |
| Low | $49.29B | $47.25B | $46.30B | $37.95B | $37.67B |
| High | $65.19B | $53.70B | $47.40B | $49.03B | $48.67B |
| EBIT Avg | $44.73B | $39.76B | $37.33B | $33.93B | $33.68B |
| Low | $39.27B | $37.65B | $36.89B | $30.23B | $30.01B |
| High | $51.94B | $42.79B | $37.77B | $39.06B | $38.78B |
| Net Income Avg | $12.31B | $9.39B | $8.21B | $8.93B | $9.14B |
| Low | $9.82B | $9.15B | $8.03B | $7.66B | $7.84B |
| High | $15.25B | $11.45B | $10.61B | $10.68B | $10.94B |
| EPS Avg | $5.13 | $4.01 | $3.60 | $3.43 | $3.51 |
| Low | $3.77 | $3.52 | $3.09 | $2.95 | $3.02 |
| High | $5.86 | $4.40 | $4.08 | $4.11 | $4.20 |
| Analysts (Rev / EPS) | 10 / 7 | 9 / 8 | 12 / 14 | 11 / 8 | 6 / 12 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $34.92B | $33.07B | $31.50B | $26.03B | $26.03B | $25.97B | $26.17B | $27.49B |
| Low | $32.31B | $30.60B | $29.15B | $24.09B | $24.08B | $24.03B | $24.21B | $25.44B |
| High | $36.83B | $34.88B | $33.22B | $27.46B | $27.45B | $27.39B | $27.60B | $29.00B |
| EBITDA Avg | $16.01B | $15.16B | $14.44B | $11.94B | $11.93B | $11.91B | $12.00B | $12.60B |
| Low | $14.81B | $14.03B | $13.36B | $11.04B | $11.04B | $11.02B | $11.10B | $11.66B |
| High | $16.89B | $15.99B | $15.23B | $12.59B | $12.59B | $12.56B | $12.65B | $13.29B |
| EBIT Avg | $12.76B | $12.08B | $11.51B | $9.51B | $9.51B | $9.49B | $9.56B | $10.04B |
| Low | $11.80B | $11.18B | $10.65B | $8.80B | $8.80B | $8.78B | $8.84B | $9.29B |
| High | $13.45B | $12.74B | $12.14B | $10.03B | $10.03B | $10.01B | $10.08B | $10.59B |
| Net Income Avg | $3.50B | $3.15B | $3.08B | $2.75B | $2.46B | $2.51B | $2.62B | $2.34B |
| Low | $3.28B | $2.81B | $2.79B | $2.48B | $2.22B | $2.26B | $2.36B | $2.12B |
| High | $3.73B | $3.47B | $3.30B | $2.94B | $2.63B | $2.68B | $2.80B | $2.51B |
| EPS Avg | $1.40 | $1.26 | $1.23 | $1.10 | $0.98 | $1.00 | $1.05 | $0.94 |
| Low | $1.31 | $1.12 | $1.11 | $0.99 | $0.89 | $0.90 | $0.94 | $0.85 |
| High | $1.49 | $1.38 | $1.32 | $1.18 | $1.05 | $1.07 | $1.12 | $1.00 |
| Analysts (Rev / EPS) | 4 / 1 | 4 / 1 | 3 / 1 | 3 / 1 | 2 / 1 | 2 / 1 | 3 / 1 | 2 / 1 |